eMedCodes logo

REOPRO - abciximab

Navigation: NDC > Supplier starting with: E > ELI LILLY AND COMPANY
Field Value
NDC Code: 0002-7140
Proprietary Name: REOPRO
Suffix:
Non-Proprietary Name: abciximab
Dosage Form: INJECTION, SOLUTION
Method: INTRAVENOUS
Original Marketing Date: 16-12-1993
Category Name: BLA
Application Number: BLA103575
Labeler: ELI LILLY AND COMPANY
Substance Name: ABCIXIMAB
Active Numerator Strength: 2
Active Ingredient Unit: mg/mL
Pharm Classes:
DEA Schedule: